je.st
news
Tag: athersys
Athersys, Inc. (ATHX) Upgraded to Buy at Zacks Investment Research
2016-03-12 01:37:03| Biotech - Topix.net
The brokerage presently has a $2.50 price target on the biopharmaceutical company's stock. Zacks Investment Research 's price objective would indicate a potential upside of 14.68% from the company's current price.
Tags: buy
research
investment
upgraded
Athersys, Inc. (ATHX) Rating Reiterated by Maxim Group
2016-02-21 17:07:58| Biotech - Topix.net
's stock had its "buy" rating reissued by equities researchers at Maxim Group in a report released on Sunday, AnalystRatings.Net reports. They currently have a $5.00 price target on the biopharmaceutical company's stock.
Tags: group
rating
maxim
athersys
Healios and Athersys Enter Into Regenerative Medicine Partnership for ...
2016-01-08 13:27:22| Biotech - Topix.net
Healios K.K. and Athersys, Inc. have announced a partnership and license agreement that will focus on the development and commercialization of novel cell therapy treatments, including MultiStemA for the treatment of ischemic stroke and potentially other indications, in Japan. The partnership involves MultiStem, a proprietary, patented off-the-shelf stem cell therapy being developed by Athersys, with an initial focus on treating ischemic stroke.
Tags: for
enter
medicine
partnership
Insider Selling: Robert J. Deans Unloads 5,080 Shares of Athersys Stock
2014-09-23 03:23:12| Biotech - Topix.net
Athersys EVP Robert J. Deans unloaded 5,080 shares of the stock in a transaction that occurred on Friday, September 19th. The stock was sold at an average price of $1.41, for a total transaction of $7,162.80.
Tags: stock
robert
selling
shares
Athersys Director Lorin Randall Sells 15,000 Shares
2014-08-20 22:05:26| Biotech - Topix.net
Athersys Director Lorin Randall sold 15,000 shares of Athersys stock on the open market in a transaction dated Monday, August 18th.
Tags: director
shares
sells
randall